Home / Pharmaceutical company intelligence
Evolution Pharmaceuticals (Pvt.) Ltd. logo
Pharmaceutical company intelligence

Evolution Pharmaceuticals products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Islamabad · Pakistan

Pakistan-based pharmaceutical manufacturer operating a GMP-oriented manufacturing facility in Rawat and marketing medicines through national distribution channels.

Evolution Pharmaceuticals products in Pakistan

Evolution Pharmaceuticals (Pvt.) Ltd has 142 medicine presentations registered in Pakistan under 49 brands, covering 47 generic medicines. Most of its products are in Anti-infectives, Gastrointestinal & hepatology and CNS & mental health. Its brands with the most registered strengths and packs are Controx (Ceftriaxone), Taxcef (Cefotaxime), Zoltum (Omeprazole, Omeprazole + Sodium bicarbonate) and Levepil (Levetiracetam). 142 products have an official DRAP price on MedInfoBase. See all 49 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation10 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check9 Aug 2026Latest source-check date across this published portfolio
Latest effective price date29 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Private pharmaceutical manufacturer
Address
Unit No. 25, 26 & 27, Street S-3, National Industrial Zone, Rawat, Islamabad, Pakistan
Phone
+92 51 4499159-61
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000867 Evolution Pharmaceuticals (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000867 143 linked products · source seen 10 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx152public portfolio records represented
REG105unique registrations represented
IDX142indexed MedInfoBase presentations
SRC2additional source-observed presentations
R+8registry-only registrations
VER40registry-verified exact registrations
PKR142current validated price records
G47generic molecules in indexed catalogue
DF8dosage-form groups
TA10therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage93%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage93%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixEvolution Pharmaceuticals (Pvt.) Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/evolution-pharmaceuticals-pvt-ltdGenerated 11 Nov 2026Anti-infectives74 · 52%Gastrointestinal & hepatology22 · 15%CNS & mental health19 · 13%Cardiovascular11 · 8%Pain & musculoskeletal6 · 4%Hematology & thrombosis3 · 2%Dermatology3 · 2%Other therapeutic areas4 · 3%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioEvolution Pharmaceuticals (Pvt.) Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/evolution-pharmaceuticals-pvt-ltdGenerated 11 Nov 2026142presentationsTablet60 · 42%Injection38 · 27%Capsule19 · 13%Cream8 · 6%Sachet8 · 6%Suspension6 · 4%Other forms3 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionEvolution Pharmaceuticals (Pvt.) Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/evolution-pharmaceuticals-pvt-ltdGenerated 11 Nov 2026132comparable productsBelow peer median64 · 48%Near peer median49 · 37%Above peer median19 · 14%Company median price position-4.5%Lowest-price equivalents13Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsEvolution Pharmaceuticals (Pvt.) Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/evolution-pharmaceuticals-pvt-ltdGenerated 11 Nov 2026Nabiqasim Industries (Pvt) Ltd.,31 shared66% overlapPharmasol (Pvt) Ltd.31 shared66% overlapZafa Pharmaceutical Laboratories (P…30 shared64% overlapCCL Pharmaceuticals (Pvt.) Limited29 shared62% overlapMediate Pharmaceutical Pvt Ltd28 shared60% overlapBosch Pharmaceuticals (Pvt) Ltd.27 shared57% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet60 products
Injection38 products
Capsule19 products
Cream8 products
Sachet8 products
Suspension6 products
Solution2 products
Ointment1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Evolution Pharmaceuticals (Pvt.) Ltd. is priced against the market

132 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers96Distinct registrations among indexed, published, presentation-validated products only
Verified price observations142
Products with a verified price142
Products with multiple price observations0
Source records with multiple versions142
Latest portfolio source check9 Aug 2026
Latest effective price date29 Jul 2026
Latest source observation10 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

105 unique registration(s) · 142 indexed presentation(s) · 2 additional source-observed presentation(s) · 8 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Acetadol Paracetamol 500 mg Tablet 500's 095370 PKR 1,818.20 PKR 3.64/tablet 🔒 Pharma Pro
Acetadol Paracetamol 500 mg Tablet 200's 095370 PKR 742.12 PKR 3.71/tablet 🔒 Pharma Pro
Adpime Injection 1g IVRegistry verified Cefepime hydrochloride eq to cefepime (with L-arginine) — — — 092071Official source ↗ No indexed price — —
Adpime Injection 2g IVRegistry verified Cefepime hydrochloride eq to cefepime (with L-arginine) — — — 092072Official source ↗ No indexed price — —
Adpime Injection 500mg IVRegistry verified Cefepime hydrochloride eq to cefepime (with L-arginine) — — — 092070Official source ↗ No indexed price — —
Ampilo Ampicillin 500 mg IV/IM injection 10's 090256 PKR 446.55 PKR 44.66/vial/unit No comparator
Avezol Cefazolin 1 g Injection 1's 087249 PKR 199.47 PKR 199.47/vial/unit 🔒 Pharma Pro
Aviflu Fluconazole 50 mg/5 mL Dry suspension 35ml 088430 PKR 418.89 PKR 11.97/mL 🔒 Pharma Pro
Avloxin Cephalexin 250 mg Capsule 12's 087254 PKR 203.46 PKR 16.96/capsule 🔒 Pharma Pro
Avloxin Cephalexin 500 mg Capsule 12's 087255 PKR 398.94 PKR 33.25/capsule 🔒 Pharma Pro
Avloxin Cephalexin 125 mg/5 mL Dry suspension 60ml 087655 PKR 117.69 PKR 1.96/mL 🔒 Pharma Pro
Azeloc Azithromycin 250 mg Capsule 6's 087682 PKR 305.19 PKR 50.87/capsule 🔒 Pharma Pro
Azeloc Azithromycin 250 mg Capsule 1 x 10's 087682 PKR 478.82 PKR 47.88/capsule 🔒 Pharma Pro
AzelocSource observed Azithromycin 200 mg Held for normalizationSource reported: Tablet · structural field conflict 15ml 090055Official source ↗ No indexed price — —
Azeloc Azithromycin 250 mg Tablet 1 x 6's 095366 PKR 291.22 PKR 48.54/tablet 🔒 Pharma Pro
Azeloc Azithromycin 250 mg Tablet 1 x 10's 095366 PKR 456.90 PKR 45.69/tablet 🔒 Pharma Pro
Azeloc Azithromycin 500 mg Tablet 1 x 6's 095367 PKR 533.91 PKR 88.99/tablet 🔒 Pharma Pro
Azeloc Dry Susp. 200mg Azithromycin 200mgSource observed — — — 15ml 090055Official source ↗ No indexed price — —
Clarevo Clarithromycin 125 mg/5 mL Dry suspension 60ml 089651 PKR 444.82 PKR 7.41/mL 🔒 Pharma Pro
Clarevo Clarithromycin 500 mg Tablet 10's 095368 PKR 776.60 PKR 77.66/tablet 🔒 Pharma Pro
Clarevo Clarithromycin 250 mg Tablet 10's 111780 PKR 339.04 PKR 33.90/tablet 🔒 Pharma Pro
Cloevo Clopidogrel 75 mg Tablet 10's 103469 PKR 210.09 PKR 21.01/tablet 🔒 Pharma Pro
Cloevo Clopidogrel 300 mg Tablet 10's 103470 PKR 510.23 PKR 51.02/tablet 🔒 Pharma Pro
Coliper Loperamide HCl 2 mg Capsule 60's 101634 PKR 305.08 PKR 5.08/capsule 🔒 Pharma Pro
Controx Ceftriaxone 250 mg Injection 10's 087236 PKR 1,820.65 PKR 182.07/vial/unit 🔒 Pharma Pro
Controx Ceftriaxone 250 mg Injection 1's 087236 PKR 201.47 PKR 201.47/vial/unit 🔒 Pharma Pro
Controx Ceftriaxone 500 mg Injection 10's 087237 PKR 3,064.37 PKR 306.44/vial/unit 🔒 Pharma Pro
Controx Ceftriaxone 500 mg IV injection 1's 087237 PKR 339.10 PKR 339.10/vial/unit 🔒 Pharma Pro
Controx Ceftriaxone 1 g IV injection 10's 087238 PKR 5,786.34 PKR 578.63/vial/unit 🔒 Pharma Pro
Controx Ceftriaxone 1 g IV injection 1's 087238 PKR 640.30 PKR 640.30/vial/unit 🔒 Pharma Pro
Controx Ceftriaxone 2 g Injection 10's 087239 PKR 8,111.74 PKR 811.17/vial/unit 🔒 Pharma Pro
Controx Ceftriaxone 2 g Injection 1's 087239 PKR 897.61 PKR 897.61/vial/unit 🔒 Pharma Pro
Controx Ceftriaxone 250 mg Injection 10's 087240 PKR 1,820.65 PKR 182.07/vial/unit 🔒 Pharma Pro
Controx Ceftriaxone 250 mg IM injection 1's 087240 PKR 201.47 PKR 201.47/vial/unit 🔒 Pharma Pro
Controx Ceftriaxone 500 mg Injection 10's 087241 PKR 3,064.37 PKR 306.44/vial/unit 🔒 Pharma Pro
Controx Ceftriaxone 500 mg Injection 1's 087241 PKR 339.10 PKR 339.10/vial/unit 🔒 Pharma Pro
DPX Valproic acid 500 mg Tablet 20's 116585 PKR 216.09 PKR 10.80/tablet 🔒 Pharma Pro
Evofenac 50mg TabletRegistry verified Diclofenac Potassium — — — 094374Official source ↗ No indexed price — —
Evolat Levofloxacin 250 mg Tablet 10's 111784 PKR 353.17 PKR 35.32/tablet 🔒 Pharma Pro
Evolat Levofloxacin 500 mg Tablet 10's 111785 PKR 587.67 PKR 58.77/tablet 🔒 Pharma Pro
Evonex Calcipotriol 0.005% Cream 30g 101640 PKR 1,281.87 PKR 42.73/g 🔒 Pharma Pro
Evonex Calcipotriol 0.005% Cream 15g 101640 PKR 640.94 PKR 42.73/g 🔒 Pharma Pro
Evonex Calcipotriol 0.005% Ointment 30g 101641 PKR 1,281.87 PKR 42.73/g 🔒 Pharma Pro
Evoprin Acetylsalicylic acid (Aspirin) 300 mg Dispersible tablet 30's 101593 PKR 97.28 PKR 3.24/tablet No comparator
Febridex Ibuprofen 200 mg Tablet 500's 095406 PKR 1,223.16 PKR 2.45/tablet 🔒 Pharma Pro
Febridex Ibuprofen 200 mg Tablet 100's 095406 PKR 244.63 PKR 2.45/tablet 🔒 Pharma Pro
Febridex Ibuprofen 400 mg Tablet 250's 095407 PKR 876.75 PKR 3.51/tablet 🔒 Pharma Pro
Febridex Ibuprofen 600 mg Tablet 30's 095408 PKR 174.74 PKR 5.82/tablet 🔒 Pharma Pro
Femcin Clindamycin 150 mg Capsule 20's 103472 PKR 171.08 PKR 8.55/capsule 🔒 Pharma Pro
Fensipro Clomifene citrate 50 mg Tablet 10's 101601 PKR 346.83 PKR 34.68/tablet 🔒 Pharma Pro
A to Z

All 49 Evolution Pharmaceuticals brands in Pakistan

  • Acetadol Paracetamol · 500 mg tablet
  • Ampilo Ampicillin · 500 mg injection
  • Avezol Cefazolin · 1 g injection
  • Aviflu Fluconazole · 50 mg/5 mL suspension
  • Avloxin Cephalexin · 125 mg/5 mL suspension, 250 mg capsule, 500 mg capsule
  • Azeloc Azithromycin · 250 mg tablet, 250 mg capsule, 500 mg tablet
  • Clarevo Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
  • Cloevo Clopidogrel · 300 mg tablet, 75 mg tablet
  • Coliper Loperamide HCl · 2 mg capsule
  • Controx Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
  • DPX Valproic acid · 500 mg tablet
  • Evolat Levofloxacin · 250 mg tablet, 500 mg tablet
  • Evonex Calcipotriol · 0.005% cream, 0.005% ointment
  • Evoprin Acetylsalicylic acid (Aspirin) · 300 mg tablet
  • Febridex Ibuprofen · 200 mg tablet, 400 mg tablet, 600 mg tablet
  • Femcin Clindamycin · 150 mg capsule
  • Fensipro Clomifene citrate · 50 mg tablet
  • Hisplex Loratadine · 10 mg tablet
  • Imitrex Sumatriptan · 50 mg tablet
  • Irosone Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
  • Itrevo Itraconazole · 100 mg capsule
  • Karnodyl Propranolol · 10 mg tablet, 40 mg tablet
  • Lagotran Lamotrigine = · 100 mg tablet, 25 mg tablet, 50 mg tablet
  • Levepil Levetiracetam · 1000 mg tablet, 250 mg tablet, 500 mg tablet
  • Linbact Linezolid · 100 mg suspension, 100 mg/5 mL suspension, 600 mg tablet
  • Losevo Losartan · 100 mg tablet, 25 mg tablet, 50 mg tablet
  • Moflaxa Moxifloxacin · 400 mg tablet
  • Moxevo Amoxicillin · 1 g injection, 250 mg injection, 500 mg injection
  • Odanex Ondansetron · 4 mg tablet, 8 mg tablet
  • Piptaz Piperacillin + tazobactam · 2 g + 250 mg injection, 4 g + 500 mg injection
  • Ponvid Povidone-iodine · 10 % solution, 10% solution
  • Rilace Plus Lisinopril + Hydrochlorothiazide · 20 mg + 12.5 mg tablet
  • Rilace Plus 10 Lisinopril + Hydrochlorothiazide · 10 mg + 12.5 mg tablet
  • Sefixim Cefixime · 200 mg/5 mL suspension, 400 mg capsule
  • Sefur Cefuroxime · 1.5 g injection, 250 mg injection, 750 mg injection
  • Setinevo Fluoxetine · 20 mg capsule
  • Silevo Silver sulfadiazine · 1 % cream, 1% cream
  • Simvax Simvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
  • Sipvox Ciprofloxacin · 250 mg tablet, 500 mg tablet
  • Talizir Thalidomide · 50 mg capsule
  • Taxcef Cefotaxime · 1 g injection, 2 g injection, 250 mg injection
  • Terbicore Terbinafine · 1 % cream, 1% cream
  • Terbicore w/w Terbinafine · 1 % cream
  • Vastia Voriconazole · 200 mg tablet
  • Vazkor Amlodipine · 5 mg tablet
  • Xenclav Amoxicillin + clavulanic acid · 1 g + 200 mg injection, 500 mg + 100 mg injection
  • Zibac Ceftazidime · 1 g injection, 250 mg injection
  • Zoltum Omeprazole, Omeprazole + Sodium bicarbonate · 20 mg capsule, 20 mg + 1680 mg sachet, 40 mg capsule
  • Zoltum Insta Omeprazole + Sodium bicarbonate · 20 mg + 1680 mg sachet, 40 mg + 1680 mg sachet
Questions

Evolution Pharmaceuticals: common questions

How many products does Evolution Pharmaceuticals have in Pakistan?

Evolution Pharmaceuticals (Pvt.) Ltd has 142 registered medicine presentations in Pakistan, sold under 49 brands and covering 47 generic medicines.

What are the main brands of Evolution Pharmaceuticals?

By number of registered strengths and packs, its largest brands are Controx (Ceftriaxone), Taxcef (Cefotaxime), Zoltum (Omeprazole, Omeprazole + Sodium bicarbonate), Levepil (Levetiracetam) and Zoltum Insta (Omeprazole + Sodium bicarbonate). This is not a sales ranking.

Which therapy areas does Evolution Pharmaceuticals cover?

The most products are in Anti-infectives (74), Gastrointestinal & hepatology (22), CNS & mental health (19), Cardiovascular (11) and Pain & musculoskeletal (6).

Where can I see Evolution Pharmaceuticals medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Evolution Pharmaceuticals (Pvt.) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/evolution-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9